PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke

被引:28
|
作者
van Goor, MLPJ
García, EG
Brouwers, GJ
Leebeek, FWG
Koudstaal, PJ
Dippel, DWJ
机构
[1] Erasmus Med Ctr, Dept Neurol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Med Ctr, Dept Hematol, Rotterdam, Netherlands
关键词
platelet glycoprotein receptor IIb IIIa; ischemic stroke; risk factors; PLAT/A2; polymorphism;
D O I
10.1016/S0049-3848(02)00356-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The relationship between the PIA2 allele of the Leu(33)Pro polymorphism of glycoprotein IIb IIIa receptor (GPIIb/IIIa) and ischemic stroke is uncertain. The purpose of this study was to investigate a possible association between the GPIIb/IIIa PI-A1/A2 polymorphism and the occurrence of cryptogenic stroke in young patients. Methods: From a consecutive series of 80 patients aged 45 or less with a recent ischemic stroke or TIA, we selected 45 patients with stroke due to small vessel occlusion or stroke of undetermined etiology (according to the TOAST criteria). Controls were 60 healthy blood donors with a similar age distribution. All patients underwent CT of the brain and were screened for cardiovascular risk factors, cardiac disorders and large vessel disease. The frequency of the PIA2 allele was determined by PCR and Msp1 restriction analysis. Results: Eight patients (16%) and 16 controls (27%) were heterozygous for PIA2 allele. Two patients (4%) were homozygous for PIA2. The relative risk of ischemic stroke associated with PIA2 allele was estimated at 0.8 (95.% CI: 0.3-1.9). Conclusion: This study does not support the association between the PIA1/A2 polymorphism and cryptogenic stroke or TIA in patients aged 45 or less. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:63 / 65
页数:3
相关论文
共 50 条
  • [31] Platelet glycoprotein IIb/IIIa inhibitors in acute ischemic stroke
    Kumar, Sudhir
    Rajshekher, G.
    Prabhakar, Subhashini
    NEUROLOGY INDIA, 2008, 56 (04) : 399 - 404
  • [32] The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health Study
    W. März
    B. O. Boehm
    B. R. Winkelmann
    M. M. Hoffmann
    Diabetologia, 2004, 47 : 1969 - 1973
  • [33] Role of platelet glycoprotein pLA1/A2 polymorphism in restenosis after percutaneous transluminal coronary angioplasty
    Abbate, R
    Marcucci, R
    Camacho-Vanegas, O
    Pepe, G
    Gori, AM
    Capanni, M
    Simonetti, I
    Prisco, D
    Gensini, GF
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04): : 524 - +
  • [34] Polymorphism of platelet glycoprotein IIb/IIIa (PIA1/A2) end risk of myocardial infarction and ischaemic stroke in Italian patients.
    Ombres, D
    Pannitteri, G
    Montenero, P
    Porcu, L
    Biscosi, C
    Montali, A
    Di Lecce, VN
    Campa, PP
    Ricci, G
    Arca, M
    ATHEROSCLEROSIS, 1999, 145 : S6 - S6
  • [35] Polymorphism A2 In platelet glycoprotein IIb/IIIa among patients with pulmonary embolism and deep venous thrombosis
    Sachdeva, M.
    Ivanov, P.
    Komsa-Penkova, R.
    Ivanov, Y.
    Beshev, I
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 81 - 82
  • [36] The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis
    Floyd, Christopher N.
    Ferro, Albert
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (03) : 446 - 457
  • [37] PlA1/PlA2 polymorphism of platelet GPIIIa receptor and microangiopathy in type 1 diabetic patients
    Pucci, L
    Nannipieri, M
    Bandinelli, S
    Pilo, M
    Mangili, R
    Navalesi, R
    Penno, G
    DIABETOLOGIA, 1998, 41 : A296 - A296
  • [38] No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction
    Lagercrantz, J
    Bergman, M
    Lundman, P
    Tornvall, P
    Hjemdahl, P
    Hamsten, A
    Eriksson, P
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (08) : 749 - 753
  • [39] Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting
    Le Hello C.
    Morello R.
    Lequerrec A.
    Duarte C.
    Riddell J.
    Hamon M.
    Thrombosis Journal, 5 (1)
  • [40] PlA1/PlA2 polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty
    Verdoia, Monica
    Pergolini, Patrizia
    Camaro, Cyril
    Restifo, Maria
    Rolla, Roberta
    Schaffer, Alon
    Di Giovine, Gabriella
    Marino, Paolo
    Bellomo, Giorgio
    Suryapranata, Harry
    De Luca, Giuseppe
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (04) : 411 - 418